Qualitek Labs Ltd

Qualitek Labs Limited has issued a corrigendum to its Extra-Ordinary General Meeting (EGM) notice, scheduled for October 16, 2026. The corrigendum clarifies and amends specific details within the Explanatory Statement concerning the preferential allotment. It addresses Point No. 11, which details the proposed allottees, their post-preferential issue shareholding, and potential impact on the company's control and equity dilution. The amendments are primarily related to discrepancies identified in the company's shareholding pattern. All other aspects of the original EGM notice and explanatory statement remain unchanged.

Qualitek Labs Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from Thursday, October 1, 2026, and will reopen 48 hours after the declaration of the Unaudited Financial Results for the quarter and half-year ended September 30, 2026. All individuals covered by the code are prohibited from trading during this period. The date of the board meeting to approve these financial results will be communicated later. The company has also made this information available on its website.

Qualitek Labs Limited has announced an Extra-Ordinary General Meeting (EGM) scheduled for October 16, 2026, to be held via video conferencing. The primary agenda is to consider and approve a preferential issue of up to 3,86,000 equity shares at ₹518.55 per share, aiming to raise approximately ₹20.01 crore. The issue is open to promoter/promoter group and non-promoter/strategic investors. Remote e-voting facility will be available from October 9 to October 15, 2026. The company has also provided the full notice of the EGM and explanatory statement on its website.

Qualitek Labs Limited announced a change in its preferential issue of securities. The Preferential Issue Committee of the Board of Directors approved the replacement of one proposed allottee, Vibha Singhi, with Jagattaraini Tieup Private Limited. Both are categorized as Non-Promoters and will receive 16,000 equity shares. All other terms of the preferential issue remain unchanged. This update follows a previous submission and is subject to regulatory and shareholder approvals.

Qualitek Labs Limited's Board of Directors has approved a preferential issue of up to 3,86,000 equity shares at ₹518.55 each, aggregating ₹20.01 crore. Additionally, the board approved the issuance of up to 5,20,000 fully convertible warrants at ₹518.55 each, aggregating ₹26.96 crore. Both issuances are subject to shareholder approval. The company also decided to convene an Extra-Ordinary General Meeting on October 16, 2026, to approve these proposals. The board meeting took place on September 22, 2026.

Qualitek Labs Ltd has announced a Board of Directors meeting scheduled for September 22, 2026. The primary agenda item is to consider and approve a proposal for fund raising through various means, including equity shares, warrants, convertible securities, rights issue, preferential allotment, private placement, or qualified institutions placement. The company may also seek shareholder approval for this fund raising. Additionally, the Board will discuss any other business with the Chair's permission. The trading window for directors and designated persons will be closed from September 17, 2026, until 48 hours after the meeting concludes.

Qualitek Labs Limited has announced the withdrawal of Agenda Item No. 4 from the notice of its upcoming Eighth Annual General Meeting (AGM) scheduled for September 25, 2026. This item proposed a special resolution to increase the overall remuneration payable to directors from 28% to 35% of net profits. The Board of Directors approved this withdrawal via a circular resolution on September 7, 2026. Consequently, this item will not be discussed or voted upon at the AGM. The existing remuneration limit of 28% remains in effect. A corrigendum to the AGM notice will be issued, and other agenda items remain unchanged.

Qualitek Labs Limited has announced the withdrawal of Agenda Item No. 4 from the notice of its upcoming Eighth Annual General Meeting (AGM) scheduled for September 25, 2026. This item pertained to a special resolution seeking approval to increase the overall remuneration payable to directors, including the Managing Director and Whole-time Directors, from 28% to 35% of the company's net profits. The Board of Directors, via a circular resolution on September 7, 2026, approved this withdrawal. Consequently, the proposed remuneration hike will not be discussed or voted upon at the AGM. The existing remuneration limit of 28% remains in effect. The company will issue a corrigendum to the AGM notice, which will also be available on its website. Other agenda items for the AGM remain unchanged.

Qualitek Labs Limited has announced its 8th Annual General Meeting (AGM) will be held on Friday, September 25, 2026, at 11:30 A.M. IST in New Delhi. The company will present its Integrated Annual Report for the Financial Year 2025-26. Members will receive the report electronically, with physical intimation sent to those without registered email addresses. The company is also facilitating remote e-voting for members from September 22 to September 24, 2026, with a cut-off date of September 18, 2026, for voting eligibility. The integrated annual report is available on the company's website.

Qualitek Labs Limited has announced that its 8th Annual General Meeting (AGM) will be held on Friday, September 25, 2026, at 11:30 A.M. IST. The meeting will take place at Avanta Business Centre in New Delhi. The company has also released its Notice convening the AGM and the Integrated Annual Report for the Financial Year 2025-26. Members will have the option for remote e-voting from September 22 to September 24, 2026, with a cut-off date of September 18, 2026, for voting eligibility. The annual report is available on the company's website.